Description
Cobamamide (also known as adenosylcobalamin or dibencozide) is an active coenzyme form of vitamin?B??. It participates in mitochondrial metabolism—specifically converting methylmalonyl?CoA to succinyl?CoA in the Krebs cycle—and supports neurological function, hematopoiesis, and energy metabolism. As a research-grade capsule, Cobamamide is ideal for in vitro or in vivo studies on metabolic disorders, vitamin B?? deficiency models, nerve regeneration, fatigue syndrome, and enzymatic cofactor mechanisms. Each box contains six 0.5?mg capsules. Strictly for laboratory research use only.
Product Specifications
| Parameter | Detail |
|---|---|
| Product Name | Cobamamide Capsules |
| Synonyms | Adenosylcobalamin; Dibencozide |
| Strength & Packaging | 0.5?mg per capsule ×?6 capsules per box |
| Dosage Form | Oral capsule |
| Manufacturer | Huayi Pharma Technology (Anhui) Co., Ltd. |
| Approval Number | SJ20213912 |
| Drug Standard Code | 86904770001192 |
| Barcode | 6975411290125 |
| CAS Number | 13870?90?1 |
| Molecular Formula | C??H???CoN??O??P |
Mechanism of Action & Research Applications
Cobamamide provides active adenosylcobalamin to support mitochondrial enzymatic reactions, neurochemical synthesis, and cellular metabolism. In research, it is used to model vitamin B??–dependent metabolic enzyme activity, cognitive and neurological support models, and hematologic or anemia-related pathways. Useful for mitochondrial energy studies and coenzyme-related signaling research.
Side Effects (For Reference Only in Research Models)
Typical clinical observations include gastrointestinal discomfort, mild nausea, headache, and rare skin rash. These mild effects help guide safe dosing parameters in experimental design.
Disclaimer
Cobamamide Capsules are strictly intended for laboratory, in vitro, or animal research use only. Not for human or veterinary therapeutic, nutritional, or diagnostic application.


Reviews
There are no reviews yet.